MSGE operates a portfolio of iconic venues, including Madison Square Garden, Radio City Music Hall, and The Chicago Theatre, and owns the Christmas Spectacular Starring the Radio City Rockettes. With a substantial fixed cost base tied to these venues, shifts in event volume tend to flow disproportionately to the bottom line, making each quarterly report a useful gauge of live-event demand. This fiscal first-quarter report stands out because it follows a record-setting concert calendar, including the start of Harry Styles' 30-night residency, and comes ahead of the key holiday season. I am watching closely to see whether strong consumer demand can continue to offset rising operating and SG&A expenses.
MSGE reported fiscal 2027 first-quarter revenue of $217.1 million, a 37% increase from $158.3 million in the prior-year period and above consensus estimates of approximately $208.2 million. Diluted earnings per share came in at $0.19, a sharp reversal from a loss of $0.46 per share a year earlier and comfortably ahead of analyst expectations of a small loss. Net income reached $8.9 million, compared with a net loss of $21.7 million in the same quarter last year.
Adjusted operating income (AOI), a non-GAAP measure that excludes items such as depreciation and share-based compensation, rose to $34.3 million from $7.1 million, an increase of $27.2 million. Operating income reached $9.7 million versus a loss of $29.7 million a year ago. Entertainment offerings revenue grew 33% to $174.9 million, food, beverage, and merchandise revenue increased 56% to $35.7 million, and arena license fees and other leasing revenue rose about 60% to $6.6 million. These gains were partially offset by higher costs, as direct operating expenses increased 24% to $126.8 million and SG&A expenses rose 18% to $66.9 million. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Despite results that handily beat consensus expectations, MSGE shares traded modestly lower in the session following the release. The muted reaction likely reflects investor focus on rising costs and the forward calendar, where management acknowledged that concert bookings at the Garden are expected to pace down in the back half of the fiscal year due to show timing. Sentiment remained broadly positive on underlying demand, however, with the company reporting that the significant majority of concerts were again sold out and that per-attendee food, beverage, and merchandise spending rose by a double-digit percentage. Strong corporate demand, including a suite license renewal rate above 95%, reinforced the view that live entertainment spending remains resilient even amid broader macroeconomic uncertainty.
Looking ahead, management reaffirmed its expectation for robust growth in both revenue and adjusted operating income for fiscal 2027, supported by a strong bookings pipeline. The company has slightly exceeded its concert booking goal at Madison Square Garden for the full fiscal year and is more than 80% of the way toward its goal across the entire venue portfolio.
Investors should monitor the holiday season closely. The 93rd run of the Christmas Spectacular launched with 231 planned performances, up from 215 last year and representing the most shows ever scheduled in a single season. Management expects to welcome over 1.2 million guests, with advanced ticket revenue pacing ahead of the prior year.
Cost trends remain a key area of focus. Direct operating expenses and SG&A both rose in the quarter on higher event volume and employee compensation, and a lighter event calendar in future quarters could pressure margins. Additionally, the potential transfer of the Infosys Theater as part of the Penn Station redevelopment remains under discussion, with any proceeds likely requiring reinvestment in a domestic venue to minimize tax implications. Capital allocation also bears watching, as the company continues to repurchase shares opportunistically under its existing authorization. From what I see, these dynamics will shape near-term performance.
In my research process, I regularly rely on Tickeron’s AI Screener to filter for stocks showing similar technical patterns and fundamental strength. This helps me quickly compare MSGE against peers and spot potential opportunities aligned with my strategy. The tool’s customizable filters on industry, performance metrics, and AI-driven signals make it a practical addition to standard analysis without replacing independent judgment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MSGE moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 35 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 40 of 47 cases where MSGE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for MSGE just turned positive on October 29, 2026. Looking at past instances where MSGE's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
Following a +2.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where MSGE advanced for three days, in 238 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
MSGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 224 of 299 cases where MSGE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MSGE as a result. In 50 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
The 10-day moving average for MSGE crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSGE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 15 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. MSGE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (82.147) is normal, around the industry mean (12.946). P/E Ratio (57.194) is within average values for comparable stocks, (39.092). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.376). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (3.589) is also within normal values, averaging (2.932).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MoviesEntertainment